What is it about?
Aspiring towards 'Better Births' may provide better outcomes. The article is about how changes to the induction of labour advice in 2001 and 2008 became policy that has brought about unlicensed practice with synthetic oxytocin for induction and enhancement of labour contractions, and management of excessive bleeding after the birth. It is about how to give the licensed treatment to improve the contractions by fine tuning the intraveonous infusion rate safely, according to the contractions and relaxations of the womb, thus reducing the incidence of predictable complications! It also is about the woman's Human Right to be informed before all treatment and also her right to say yes, or no, or stop! to any procedure. This complies with the legal obligations under medical and NMC Codes of Practice. Research, for the article found no evidence that women were receiving the information that unlicensed practice was intended, nor were they being asked, formally, to consent to unlicensed practices.
Photo by Jonathan Borba on Unsplash
Why is it important?
It is important because there is no evidence that outcomes have improved as a result of the changes, and because the changes could have been reversed as soon as statistics showed fewer best outcomes. Women receiving this treatment are warned that they are likely to need an epidural to cope with the pain, and more babies are born by ceasarian section, and many more women experience abnormal bleeding in the first few hours after the birth. Reducing the time a woman stays in the labour room is a reasonable aspiration, but what price will she pay in complications and their resolutions, by having her labour accelerated with an unlicensed use of a drug?
Read the Original
This page is a summary of: Postpartum haemorrhage and synthetic oxytocin dilutions in labour, British Journal of Midwifery, October 2021, Mark Allen Group, DOI: 10.12968/bjom.2021.29.10.590.
You can read the full text:
Post Partum Haemorrhage (PPH) and synthetic oxytocin diutions in obstetric labour
it is about how changes to the induction of labour policy in the UK in 2001 and 2008 and practice has brought about the unlicensed oxytocin use or induction,augmentation and post partum management of PPH. it is about how to give the licensed dilution and dose to maximise the efficacy of contraction by fine tuning the intraveonous infusion rate, according to the contractions and relaxations of the womb. Website: http://oxytocinmeaures.com
Induction of Labour Challenging unlicensed synthetic oxytocin
it is about how changes to the induction of labour policy in 2001 and 2008 and practice has brought about the unlicensed oxytocin use or induction,augmentation and post partum management of PPH. it is about how to give the licensed dilution and dose to maximise the efficacy of contraction by fine tuning the intraveonous infusion rate, according to the contractions and relaxations of the womb. It is also about having a "Better Birth"
Induction of Labour - Challenging Unlicensed Synthetic Oxytocin
Induction with synthetic oxytocin: less is more
Short illustrated article for AIMS drawing attention to the way synthetic oxytocin should be administered as directed by the instructions, the legal obligation of obstetric professionals to justify, inform, and give choice to women prior to any unlicensed use of a medicine; in the context that unlicensed use of synthetic oxytocin cannot guarantee a shorter labour nor a better outcome (with citations).
Care of the Uterus in Labour to reduce the Incidence of Postparum Haemorrhage when using Unlicensed Dilutions of Synthetic Oxytocin
Slide presentation directing to our resources for clinical practice and teaching; covering licensed practice with synthetic oxytocin, calculation of 'allowable blood loss'; consent to unlicensed treatment - especially because it is designed to cause pain - is legally required. Additional slides covering oxytocin receptor desensitisation were not uploaded to YouTube but they, and the missing audio files (and original voiceover text), are available from email@example.com.
The following have contributed to this page